UK start-up George Medicines has named Mark Mallon as its new chief executive, who will oversee the company as it tries to get its triple therapy for high blood pressure over the finish line.

and former product and portfolio strategy chief Mark Mallon. But while Jallal and Mallon left for roles as CEOs of biotech companies – Immunocore and Ironwood respectively, Bohen has seemingly ...

Donald Trump’s ‘drill, baby, drill” campaign promise was empty words that are not expected to have any impact on output in ...

Oil and gas producers in the US will not raise output significantly in the coming years despite calls from President-Elect ...

Oil and gas producers in the U.S. will not raise output significantly in the coming years despite calls from President-elect ...